BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 30224067)

  • 1. Effect of growth differentiation factor-15 secreted by human umbilical cord blood-derived mesenchymal stem cells on amyloid beta levels in in vitro and in vivo models of Alzheimer's disease.
    Kim DH; Lee D; Lim H; Choi SJ; Oh W; Yang YS; Chang JH; Jeon HB
    Biochem Biophys Res Commun; 2018 Oct; 504(4):933-940. PubMed ID: 30224067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GDF-15 secreted from human umbilical cord blood mesenchymal stem cells delivered through the cerebrospinal fluid promotes hippocampal neurogenesis and synaptic activity in an Alzheimer's disease model.
    Kim DH; Lee D; Chang EH; Kim JH; Hwang JW; Kim JY; Kyung JW; Kim SH; Oh JS; Shim SM; Na DL; Oh W; Chang JW
    Stem Cells Dev; 2015 Oct; 24(20):2378-90. PubMed ID: 26154268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombospondin-1 secreted by human umbilical cord blood-derived mesenchymal stem cells rescues neurons from synaptic dysfunction in Alzheimer's disease model.
    Kim DH; Lim H; Lee D; Choi SJ; Oh W; Yang YS; Oh JS; Hwang HH; Jeon HB
    Sci Rep; 2018 Jan; 8(1):354. PubMed ID: 29321508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble intracellular adhesion molecule-1 secreted by human umbilical cord blood-derived mesenchymal stem cell reduces amyloid-β plaques.
    Kim JY; Kim DH; Kim JH; Lee D; Jeon HB; Kwon SJ; Kim SM; Yoo YJ; Lee EH; Choi SJ; Seo SW; Lee JI; Na DL; Yang YS; Oh W; Chang JW
    Cell Death Differ; 2012 Apr; 19(4):680-91. PubMed ID: 22015609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Umbilical Cord Mesenchymal Stem Cells Conditioned Medium Promotes Aβ25-35 phagocytosis by Modulating Autophagy and Aβ-Degrading Enzymes in BV2 Cells.
    Xu Z; Nan W; Zhang X; Sun Y; Yang J; Lu K; Liu Y; Gao Y; Yang F; Mao W; Xing X; Du J; Li H; Li Y; Feng H; Yuan Z; Lin J
    J Mol Neurosci; 2018 Jun; 65(2):222-233. PubMed ID: 29845511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease.
    Lee HJ; Lee JK; Lee H; Shin JW; Carter JE; Sakamoto T; Jin HK; Bae JS
    Neurosci Lett; 2010 Aug; 481(1):30-5. PubMed ID: 20600610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cooperative therapeutic action of retinoic acid receptor and retinoid x receptor agonists in a mouse model of Alzheimer's disease.
    Kawahara K; Suenobu M; Ohtsuka H; Kuniyasu A; Sugimoto Y; Nakagomi M; Fukasawa H; Shudo K; Nakayama H
    J Alzheimers Dis; 2014; 42(2):587-605. PubMed ID: 24916544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosomes Isolated From Human Umbilical Cord Mesenchymal Stem Cells Alleviate Neuroinflammation and Reduce Amyloid-Beta Deposition by Modulating Microglial Activation in Alzheimer's Disease.
    Ding M; Shen Y; Wang P; Xie Z; Xu S; Zhu Z; Wang Y; Lyu Y; Wang D; Xu L; Bi J; Yang H
    Neurochem Res; 2018 Nov; 43(11):2165-2177. PubMed ID: 30259257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble CCL5 derived from bone marrow-derived mesenchymal stem cells and activated by amyloid β ameliorates Alzheimer's disease in mice by recruiting bone marrow-induced microglia immune responses.
    Lee JK; Schuchman EH; Jin HK; Bae JS
    Stem Cells; 2012 Jul; 30(7):1544-55. PubMed ID: 22570192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrillar Aβ triggers microglial proteome alterations and dysfunction in Alzheimer mouse models.
    Sebastian Monasor L; Müller SA; Colombo AV; Tanrioever G; König J; Roth S; Liesz A; Berghofer A; Piechotta A; Prestel M; Saito T; Saido TC; Herms J; Willem M; Haass C; Lichtenthaler SF; Tahirovic S
    Elife; 2020 Jun; 9():. PubMed ID: 32510331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against RAGE-mediated neuronal cell death by sRAGE-secreting human mesenchymal stem cells in 5xFAD transgenic mouse model.
    Son M; Oh S; Park H; Ahn H; Choi J; Kim H; Lee HS; Lee S; Park HJ; Kim SU; Lee B; Byun K
    Brain Behav Immun; 2017 Nov; 66():347-358. PubMed ID: 28760504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain-derived neurotrophic factor modified human umbilical cord mesenchymal stem cells-derived cholinergic-like neurons improve spatial learning and memory ability in Alzheimer's disease rats.
    Hu W; Feng Z; Xu J; Jiang Z; Feng M
    Brain Res; 2019 May; 1710():61-73. PubMed ID: 30586546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation.
    Lee HJ; Lee JK; Lee H; Carter JE; Chang JW; Oh W; Yang YS; Suh JG; Lee BH; Jin HK; Bae JS
    Neurobiol Aging; 2012 Mar; 33(3):588-602. PubMed ID: 20471717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer's disease model.
    Kim KS; Kim HS; Park JM; Kim HW; Park MK; Lee HS; Lim DS; Lee TH; Chopp M; Moon J
    Neurobiol Aging; 2013 Oct; 34(10):2408-20. PubMed ID: 23623603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
    Baik SH; Kang S; Son SM; Mook-Jung I
    Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
    Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
    Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
    Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced amyloid-β degradation in early Alzheimer's disease but not in the APPswePS1dE9 and 3xTg-AD mouse models.
    Stargardt A; Gillis J; Kamphuis W; Wiemhoefer A; Kooijman L; Raspe M; Benckhuijsen W; Drijfhout JW; Hol EM; Reits E
    Aging Cell; 2013 Jun; 12(3):499-507. PubMed ID: 23534431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice.
    Hickman SE; Allison EK; El Khoury J
    J Neurosci; 2008 Aug; 28(33):8354-60. PubMed ID: 18701698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-inflammatory Annexin A1 induces the clearance and degradation of the amyloid-β peptide.
    Ries M; Loiola R; Shah UN; Gentleman SM; Solito E; Sastre M
    J Neuroinflammation; 2016 Sep; 13(1):234. PubMed ID: 27590054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.